Through a case of acute coronary syndrome(ACS)after percutaneous coronary intervention(PCI)caused by intrastent thrombosis(IST),clinical pharmacists analyze the possible cause of IST and participate in the adjustment of drug treatment and provide comprehensive pharmaceutical services,intended to improve medication treatment effect,reduce complications,and ultimately improve the patient′s prognosis.This reflects the value of clini-cal pharmacists in clinical medication treatment.
维普
万方数据